Do you want to read an article? Please log in or register.
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics
Related content
RECOMMENDED
Asthma
Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function
Respir Med.
Mansur AH, Srivastava S, Sahal A
doi: 10.1016/j.rmed.2018.08.005.
IgE sensitisation to food allergens and airborne allergens in relation to biomarkers of type 2 inflammation in asthma
Clin Exp Allergy.
Patelis A, Alving K, Middelveld R, James A, Ono J, Ohta S, Izuhara K, Borres MP, Forsberg B, Janson C, Malinovschi A
doi: 10.1111/cea.13165.
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Type 2 Diabetic Patients
J Clin Endocrinol Metab.
López-Cano C, Lecube A, García-Ramírez M, Muñoz X, Sánchez E, Seminario A, Hernández M, Ciudin A, Gutiérrez L, Hernández C, Simó R
doi: 10.1210/jc.2017-00913.
RECOMMENDED
Sleep Apnea
Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial
Eur Respir J.
West SD, Prudon B, Hughes J, Gupta R, Mohammed SB, Gerry S, Stradling JR; ROSA trial investigators
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Fibrosis
Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Barochia AV, Kaler M, Weir N, Gordon EM, Figueroa DM, Yao X, WoldeHanna ML, Sampson M, Remaley AT, Grant G, Barnett SD, Nathan SD, Levine SJ
doi: 10.1183/13993003.04053-2020
COMMENTED
Asthma
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID, investigators for the MRC Refractory Asthma Stratification Programme.
doi: 10.1016/S2213-2600(20)30397-0.
RECOMMENDED
Asthma
Meeting the Challenge of Identifying New Treatments for Type 2-low Neutrophilic Asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Kalchiem-Dekel O, Yao X, Levine SJ
doi: 10.1016/j.chest.2019.08.2192.
Sleep Apnea
Aiding sleep in type 2 diabetes: therapeutic considerations
Lancet Diabetes Endocrinol.
Tan X, van Egmond L, Chapman CD, Cedernaes J, Benedict C
doi: 10.1016/S2213-
RECOMMENDED
Further Publications
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, Johnston J, Molfino N, Parnes JR, Megally A, Colice G, Brightling CE
doi: 10.1016/S2213-2600(21)00226-5